Cargando…
Characterization of different CTC subpopulations in non-small cell lung cancer
Circulating tumour cells (CTCs) serve as valuable biomarkers. However, EpCAM positive CTCs are less frequently detected in NSCLC patients compared to other epithelial tumours. First, EpCAM protein expression was analysed in primary and metastatic lung cancer tissue. In both groups 21% of the samples...
Autores principales: | Hanssen, Annkathrin, Wagner, Jenny, Gorges, Tobias M., Taenzer, Aline, Uzunoglu, Faik G., Driemel, Christiane, Stoecklein, Nikolas H., Knoefel, Wolfram T., Angenendt, Sebastian, Hauch, Siegfried, Atanackovic, Djordje, Loges, Sonja, Riethdorf, Sabine, Pantel, Klaus, Wikman, Harriet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908396/ https://www.ncbi.nlm.nih.gov/pubmed/27302574 http://dx.doi.org/10.1038/srep28010 |
Ejemplares similares
-
Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer
por: Hanssen, Annkathrin, et al.
Publicado: (2015) -
Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease
por: Hanssen, Annkathrin, et al.
Publicado: (2018) -
EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients
por: Scharpenseel, Heather, et al.
Publicado: (2019) -
Tumor-Stroma Interaction in PDAC as a New Approach for Liquid Biopsy and its Potential Clinical Implications
por: Götze, Julian, et al.
Publicado: (2022) -
Loss of 4q21.23-22.1 Is a Prognostic Marker for Disease Free and Overall Survival in Non-Small Cell Lung Cancer
por: Uzunoglu, Faik G., et al.
Publicado: (2014)